These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22711748)

  • 1. Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics.
    Nagar S; Korzekwa K
    Drug Metab Dispos; 2012 Sep; 40(9):1649-52. PubMed ID: 22711748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the intestinal first-pass metabolism of CYP3A and UGT substrates in humans from in vitro data.
    Nishimuta H; Sato K; Yabuki M; Komuro S
    Drug Metab Pharmacokinet; 2011; 26(6):592-601. PubMed ID: 21878741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of the unbound drug concentration in enzyme kinetics.
    Waters NJ; Obach RS; Di L
    Methods Mol Biol; 2014; 1113():119-45. PubMed ID: 24523111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE
    Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modulation of the receptors during interaction with pharmacologically active substances (review of the literature)].
    Seĭfulla RD
    Farmakol Toksikol; 1976; 39(4):492-500. PubMed ID: 1027576
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
    Dobson PD; Kell DB
    Nat Rev Drug Discov; 2008 Mar; 7(3):205-20. PubMed ID: 18309312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Models to predict unbound intracellular drug concentrations in the presence of transporters.
    Korzekwa KR; Nagar S; Tucker J; Weiskircher EA; Bhoopathy S; Hidalgo IJ
    Drug Metab Dispos; 2012 May; 40(5):865-76. PubMed ID: 22279052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporters--the view from industry.
    Kohl C
    Chem Biodivers; 2009 Nov; 6(11):1988-99. PubMed ID: 19937835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surface membrane proteins of endoplasmic reticulum in brain and liver cells].
    Gurevich VS; Beliavtseva LM
    Biokhimiia; 1976 Apr; 41(4):699-702. PubMed ID: 1022295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins.
    Shikano S; Coblitz B; Wu M; Li M
    Trends Cell Biol; 2006 Jul; 16(7):370-5. PubMed ID: 16769213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
    Sun H; Pang KS
    Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Xenobiotica; 2009 Mar; 39(3):227-35. PubMed ID: 19280521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans.
    Velický M; Tam KY; Dryfe RA
    Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery.
    Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R
    Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and tissue binding considerations in drug disposition.
    Wilkinson GR
    Drug Metab Rev; 1983; 14(3):427-65. PubMed ID: 6347593
    [No Abstract]   [Full Text] [Related]  

  • 20. Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition.
    Smith D; Artursson P; Avdeef A; Di L; Ecker GF; Faller B; Houston JB; Kansy M; Kerns EH; Krämer SD; Lennernäs H; van de Waterbeemd H; Sugano K; Testa B
    Mol Pharm; 2014 Jun; 11(6):1727-38. PubMed ID: 24724562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.